Moddy's Positive on Clorox's (CLX) Acquisition of Renew Life; No Ratings Impact Expected
Get Alerts CLX Hot Sheet
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 3.1%
Revenue Growth %: -0.5%
Join SI Premium – FREE
Moody's Investors Service commented that The Clorox Company's (NYSE: CLX) announced acquisition of Renew Life Holding Corporation is credit positive, but has no effect on the company's ratings. On May 3, 2016, Clorox announced it had acquired Renew Life, a producer of digestive wellness supplements, for approximately $290 million. For more details please see the Issuer Comment published May 3, 2016. This publication does not announce a credit rating action. For any credit ratings referenced in this publication, please see the ratings tab on the issuer/entity page on www.moodys.com for the most updated credit rating action information and rating history.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Upgrades Clorox (CLX) to Hold, Sees limited scope for downside
- Teleperformance (TEP:FP) (TLPFY) PT Lowered to EUR125 at RBC Capital, 'perceived risk profile makes it a no-fly zone for many investors'
- H.C. Wainwright Reiterates Buy Rating on Acrivon Therapeutics Inc (ACRV), views ACR-368 'benefit/risk as favorable'
Create E-mail Alert Related Categories
Credit RatingsRelated Entities
Moody's Investors Service, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!